84 - Diagnostic Clinical Cases: What Do I Do With This Test Result?

Monday, October 20, 2025

3:15 PM - 4:30 PM US ET

Location: Sidney J. Marcus Auditorium

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

RB

Ritu Banerjee, MD, Ph.D (she/her/hers)

Professor
Pediatric Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States

Interactive Moderator(s)

Christopher Doern, PhD (he/him/his)

Director, Clinical Microbiology
Virginia Commonwealth University Health System
Richmond, VA, United States

Slides
SB

Susan Butler-Wu, PhD, D(ABMM), FIDSA

Associate Professor, Clinical Pathology
Keck School of Medicine of USC, CA, United States

Panelist(s)

AK

Anna Kaltsas, MD, MS, FIDSA (she/her/hers)

Assistant Attending
Infectious Diseases Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY, United States
MS

Marco Scipione, PharmD, BCIDP

Infectious Diseases Clinical Pharmacy Specialist
Pharmacy
Detroit Receiving Hospital
Detroit, MI, United States
Alexander McAdam, MD, PhD, D(ABMM) (he/him/his)

Chief, Department of Laboratory Medicine
Boston Children's Hospital
ER

Elizabeth Robilotti, MD MPH

Attending Physician
Hospital for Special Surgery
Amanda Harrington, PhD

Director, Clinical Microbiological Laboratory
Loyola University Chicago
Maywood, IL, United States

Disclosure(s):

Ritu Banerjee, MD, Ph.D: Biomerieux/Biofire diagnositcs: Grant/Research Support

Christopher Doern, PhD: Karius, Inc: Honoraria; Roche Diagnostics: Advisor/Consultant; Shionogi Pharmacovigilance Center Co., Ltd.: Honoraria

Susan Butler-Wu, PhD, D(ABMM), FIDSA: Biomerieux/Biofire diagnositcs: Advisor/Consultant

Anna Kaltsas, MD, MS, FIDSA: No financial relationships to disclose.

Marco R. Scipione, PharmD, BCIDP: No financial relationships to disclose.

Alexander McAdam, MD, PhD, D(ABMM): No financial relationships to disclose.

Elizabeth Robilotti, MD MPH: Replimune: Advisor/Consultant

Amanda Harrington, PhD: CARB-X: Advisor/Consultant

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify the limitations of diagnostic tests;
explain how to understand sensitivity and specificity of newer diagnostic tests;
use pretest probability to more appropriately order diagnostic tests.